Aveanna Healthcare (AVAH) Stock Forecast, Price Target & Predictions
AVAH Stock Forecast
Aveanna Healthcare (AVAH) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $4.10, with a high of $6.00 and a low of $2.00. This represents a -10.09% decline from the last price of $4.56.
AVAH Stock Rating
Aveanna Healthcare stock's rating consensus is Hold, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (30.00%), 5 Hold (50.00%), 2 Sell (20.00%), and 0 Strong Sell (0.00%).
Hold
AVAH Price Target Upside V Benchmarks
Type | Name | Upside |
---|---|---|
Stock | Aveanna Healthcare | -10.09% |
Sector | Healthcare Stocks | 33.91% |
Industry | Medical Care Facilities Stocks | 22.50% |
Price Target Trends
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $5.00 |
Last Closing Price | $4.56 | $4.56 | $4.56 |
Upside/Downside | - | - | 9.65% |
Ratings Trends
Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
---|---|---|---|---|---|---|
Apr, 25 | - | 1 | 5 | 1 | 1 | 8 |
Mar, 25 | - | 1 | 5 | 1 | 1 | 8 |
Feb, 25 | - | 1 | 5 | 1 | 1 | 8 |
Jan, 25 | - | 1 | 5 | 1 | 1 | 8 |
Dec, 24 | - | 1 | 5 | 1 | 1 | 8 |
Analyst Price Target Forecasts
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 09, 2024 | Ben Hendrix | RBC Capital | $5.00 | $4.87 | 2.67% | 9.65% |
Nov 17, 2022 | Credit Suisse | $2.00 | $0.80 | 150.00% | -56.14% | |
Aug 19, 2022 | Barclays | $5.00 | $2.13 | 134.74% | 9.65% | |
Aug 15, 2022 | Raymond James | $6.00 | $2.14 | 180.37% | 31.58% | |
Jul 12, 2022 | David MacDonald | Truist Financial | $2.50 | $2.49 | 0.40% | -45.18% |
Analyst Rating Forecasts
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 09, 2024 | Deutsche Bank | Buy | Buy | hold |
Aug 09, 2024 | RBC Capital | Sector Perform | Sector Perform | hold |
Nov 17, 2022 | Credit Suisse | Neutral | downgrade | |
Nov 16, 2022 | Raymond James | Strong Buy | Strong Buy | hold |
Aug 19, 2022 | Barclays | Overweight | Overweight | hold |
Aug 15, 2022 | Raymond James | Strong Buy | Strong Buy | hold |
Financial Forecast
EPS Forecast
Annual
Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|
Reported | $-0.63 | $-3.57 | $-0.71 | $-0.06 | - | - | - |
Avg Forecast | $0.42 | $0.02 | $-0.11 | $0.01 | $0.08 | $0.15 | $0.27 |
High Forecast | $0.42 | $0.02 | $-0.11 | $0.01 | $0.16 | $0.18 | $0.27 |
Low Forecast | $0.42 | $0.02 | $-0.12 | $-0.01 | $0.03 | $0.11 | $0.27 |
Surprise % | -250.00% | -17950.00% | 545.45% | -700.00% | - | - | - |
Revenue Forecast
Annual
Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|
Reported | $1.68B | $1.79B | $1.90B | $2.02B | - | - | - |
Avg Forecast | $1.68B | $1.78B | $1.88B | $2.00B | $2.11B | $2.21B | $2.34B |
High Forecast | $1.69B | $1.80B | $1.89B | $2.01B | $2.12B | $2.21B | $2.35B |
Low Forecast | $1.67B | $1.78B | $1.87B | $1.99B | $2.10B | $2.21B | $2.32B |
Surprise % | -0.21% | 0.17% | 0.74% | 1.01% | - | - | - |
Net Income Forecast
Annual
Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|
Reported | $-117.04M | $-662.03M | $-134.52M | $-10.93M | - | - | - |
Avg Forecast | $8.75M | $9.62M | $-134.52M | $5.01K | $21.16M | $30.54M | $51.23M |
High Forecast | $10.50M | $11.54M | $-107.62M | $1.54M | $31.30M | $33.24M | $51.62M |
Low Forecast | $7.00M | $7.70M | $-161.43M | $-1.53M | $6.26M | $20.32M | $50.84M |
Surprise % | -1438.28% | -6981.52% | - | -218309.04% | - | - | - |